(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 6531.70 | 6030.50 | 8.31 | 6531.70 | 6030.50 | 8.31 | 25196.50 | 22813.50 | 10.45 |
| Other Income | 448.40 | 671.70 | -33.24 | 448.40 | 671.70 | -33.24 | 1879.50 | 1722.50 | 9.11 |
| PBIDT | 2924.00 | 2771.90 | 5.49 | 2924.00 | 2771.90 | 5.49 | 10920.40 | 9124.80 | 19.68 |
| Interest | 14.60 | 32.50 | -55.08 | 14.60 | 32.50 | -55.08 | 94.80 | 84.10 | 12.72 |
| PBDT | 2909.40 | 2739.40 | 6.21 | 2909.40 | 2739.40 | 6.21 | 10334.00 | 10768.80 | -4.04 |
| Depreciation | 142.60 | 144.10 | -1.04 | 142.60 | 144.10 | -1.04 | 577.30 | 607.90 | -5.03 |
| PBT | 2766.80 | 2595.30 | 6.61 | 2766.80 | 2595.30 | 6.61 | 9756.70 | 10160.90 | -3.98 |
| TAX | 722.10 | 677.80 | 6.54 | 722.10 | 677.80 | 6.54 | 2532.40 | 2484.90 | 1.91 |
| Deferred Tax | 12.80 | 3.90 | 228.21 | 12.80 | 3.90 | 228.21 | -42.80 | -156.10 | -72.58 |
| PAT | 2044.70 | 1917.50 | 6.63 | 2044.70 | 1917.50 | 6.63 | 7224.30 | 7676.00 | -5.88 |
| Equity | 457.50 | 457.50 | 0.00 | 457.50 | 457.50 | 0.00 | 457.50 | 457.50 | 0.00 |
| PBIDTM(%) | 44.77 | 45.96 | -2.61 | 44.77 | 45.96 | -2.61 | 43.34 | 40.00 | 8.36 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1990.00 |
| Dr. Reddys Labs. | 1142.00 |
| Cipla | 1473.70 |
| Lupin | 2445.40 |
| Zydus Lifesciences | 1123.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: